Barbara A. Hendrickson

Infectious Disease

5721 S Maryland Ave
Chicago, IL 60637

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Publicly Available Clinical Trial Safety Data: Review and a Call for Standardization and Improved Reporting Practices.

Publicly Available Clinical Trial Safety Data: Review and a Call for Standardization and Improved Reporting Practices.

Journal: Pharmaceutical medicine

Published: November 26, 2025

How Aggregate Safety Assessment Planning Supports Investigational New Drug Safety Reporting Decisions.

How Aggregate Safety Assessment Planning Supports Investigational New Drug Safety Reporting Decisions.

Journal: Therapeutic innovation & regulatory science

Published: October 24, 2023

Fibrosing Mediastinitis Caused by Histoplasmosis in an Adolescent.

Fibrosing Mediastinitis Caused by Histoplasmosis in an Adolescent.

Journal: JACC. Case reports

Published: September 27, 2023

Aggregate IND Safety Reporting for Smaller Companies and Programs.

Aggregate IND Safety Reporting for Smaller Companies and Programs.

Journal: Therapeutic innovation & regulatory science

Published: July 29, 2023

Value and Implementation of the Aggregate Safety Assessment Plan.

Value and Implementation of the Aggregate Safety Assessment Plan.

Journal: Pharmaceutical medicine

Published: March 09, 2023

Assessing adverse events in clinical trials during the era of the COVID-19 pandemic.

Assessing adverse events in clinical trials during the era of the COVID-19 pandemic.

Journal: Journal of biopharmaceutical statistics

Published: January 31, 2023

Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies.

Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies.

Journal: The Journal of allergy and clinical immunology

Published: April 28, 2022

Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study.

Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study.

Journal: RMD open

Published: November 15, 2021

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: December 11, 2020

Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluation.

Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluation.

Journal: Pharmaceutical statistics

Published: December 08, 2020

Aggregate Safety Assessment Planning for the Drug Development Life-Cycle.

Aggregate Safety Assessment Planning for the Drug Development Life-Cycle.

Journal: Therapeutic innovation & regulatory science

Published: December 06, 2020

Interdisciplinary Safety Evaluation for Learning and Decision-Making.

Interdisciplinary Safety Evaluation for Learning and Decision-Making.

Journal: Therapeutic innovation & regulatory science

Published: October 07, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026